Bacterial Pathogens and Antibiotic Resistance in Bloodstream Infections in Tunisia: A 13-Year Trend Analysis
- PMID: 40559731
- PMCID: PMC12197613
- DOI: 10.3390/tropicalmed10060164
Bacterial Pathogens and Antibiotic Resistance in Bloodstream Infections in Tunisia: A 13-Year Trend Analysis
Abstract
The antimicrobial resistance (AMR) surveillance network has been monitoring bloodstream bacterial pathogens and their resistance since 1999 in Tunisia. We report the long-term trends in the distribution of bloodstream bacterial pathogens and their resistance patterns from this surveillance database. We analyzed antibiotic resistance rates in 11 tertiary teaching hospital laboratories under the AMR surveillance network during 2011-2023, focusing on six priority bacterial pathogens, using the Cochrane-Armitage test for trend analysis. Of 22,795 isolates, K. pneumoniae (38.5%) was the most common, followed by S. aureus (20.4%), E. coli (13.6%), and A. baumannii (10.3%). Carbapenem resistance was highest in A. baumannii (77%), followed by Pseudomonas aeruginosa (29.3%), K. pneumoniae (19.4%), and Enterobacter cloacae (6.8%). Carbapenem-resistant Enterobacterales and third-generation cephalosporin-resistant Enterobacterales (3GCREB) increased from 10.6% to 26.3% (p-value < 0.001), and from 39% to 50.2%, respectively, during 2011-2023 (p-value < 0.001). Vancomycin resistance (38.3%) and the emergence of linezolid resistance in 2019 (2.4%) were reported in E. faecium isolates. Resistance to carbapenems and 3GC is a major challenge to controlling BSI in Tunisia. The national AMR surveillance network helps monitor annual patterns and guides empirical therapy. An integrated database combining clinical profiles and resistance data via real-time data-sharing platforms could improve clinical decision-making.
Keywords: GLASS; SORT-IT; antimicrobial resistance surveillance; carbapenem resistant Enterobacterales; operational research.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Stewardson A.J., Allignol A., Beyersmann J., Graves N., Schumacher M., Meyer R., Tacconelli E., De Angelis G., Farina C., Pezzoli F., et al. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: A multicentre retrospective cohort study. Eurosurveillance. 2016;21:30319. doi: 10.2807/1560-7917.ES.2016.21.33.30319. - DOI - PMC - PubMed
-
- WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed. [(accessed on 26 November 2023)]. Available online: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-....
-
- Marchello C.S., Dale A.P., Pisharody S., Rubach M.P., Crump J.A. A Systematic Review and Meta-analysis of the Prevalence of Community-Onset Bloodstream Infections among Hospitalized Patients in Africa and Asia. Antimicrob. Agents Chemother. 2019;64:e01974-19. doi: 10.1128/AAC.01974-19. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
